Serum endocan concentration in women with pre-eclampsia

Archives of Gynecology and Obstetrics

Volumn 292, Issue 1, 2015, Pages 69-73

  Yuksel, Mehmet Aytac ^a   Tuten, Abdullah ^a   Oncul, Mahmut ^a   Acikgoz, Abdullah Serdar ^a   Temel Yuksel, Ilkbal ^b   Toprak, Muhammet Sait ^a   Ekmekci, Hakan ^a   Balci Ekmekci, Ozlem ^a   Madazli, Riza ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Okmeydani Research and Training Hospital   (Turkey)

Author keywords

Endocan; Inflammation; Pre eclampsia

Indexed keywords

ESM1 PROTEIN, HUMAN; PROTEOGLYCAN; TUMOR PROTEIN;

ADULT; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; UTERINE ARTERY; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; NEOPLASM PROTEINS; PRE-ECLAMPSIA; PREGNANCY; PROTEOGLYCANS; UTERINE ARTERY; YOUNG ADULT;

EID: 84939958281     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-014-3605-x     Document Type: Article

References (26)

1. Sibai BM (2006) Preeclampsia as a cause of preterm and late preterm (near-term) births. Semin Perinatol 30(1):16–19. doi:10.1053/j.semperi.2006.01.008
2. Turner JA (2010) Diagnosis and management of pre-eclampsia: an update. Int J Women’s Health 2:327–337. doi:10.2147/IJWH.S8550
3. Roberts JM, Lain KY (2002) Recent insights into the pathogenesis of pre-eclampsia. Placenta 23(5):359–372. doi:10.1053/plac.2002.0819
4. Pennington KA, Schlitt JM, Jackson DL, Schulz LC, Schust DJ (2012) Preeclampsia: multiple approaches for a multifactorial disease. Dis Models Mech 5(1):9–18. doi:10.1242/dmm.008516
5. Lam C, Lim KH, Karumanchi SA (2005) Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46(5):1077–1085. doi:10.1161/01.HYP.0000187899.34379.b0
6. Lassalle P, Molet S, Janin A, Heyden JV, Tavernier J, Fiers W, Devos R, Tonnel AB (1996) ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 271(34):20458–20464
7. Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C, Lortat-Jacob H, Bechard D, Lassalle P, Delehedde M (2006) Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta 1765(1):25–37. doi:10.1016/j.bbcan.2005.08.004
8. Bechard D, Meignin V, Scherpereel A, Oudin S, Kervoaze G, Bertheau P, Janin A, Tonnel A, Lassalle P (2000) Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vasc Res 37(5):417–425 25758
9. Mihajlovic DM, Lendak DF, Brkic SV, Draskovic BG, Mitic GP, Novakov Mikic AS, Cebovic TN (2014) Endocan is useful biomarker of survival and severity in sepsis. Microvasc Res 93:92–97. doi:10.1016/j.mvr.2014.04.004
10. Ozaki K, Toshikuni N, George J, Minato T, Matsue Y, Arisawa T, Tsutsumi M (2014) Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma. J Cancer 5(3):221–230. doi:10.7150/jca.7691
11. Balta I, Balta S, Koryurek OM, Demirkol S, Mikhailidis DP, Celik T, Cakar M, Kucuk U, Eksioglu M, Kurt YG (2014) Serum endocan levels as a marker of disease activity in patients with Behcet disease. J Am Acad Dermatol 70(2):291–296. doi:10.1016/j.jaad.2013.09.013
12. Leroy X, Aubert S, Zini L, Franquet H, Kervoaze G, Villers A, Delehedde M, Copin MC, Lassalle P (2010) Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology 56(2):180–187. doi:10.1111/j.1365-2559.2009.03458.x
13. Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP (2005) Preeclampsia: a renal perspective. Kidney Int 67(6):2101–2113. doi:10.1111/j.1523-1755.2005.00316.x
14. ACOG practice bulletin (2002) Diagnosis and management of preeclampsia and eclampsia. Number 33. Obstet Gynecol 99(1):159–167
15. Chaiworapongsa T, Romero R, Kusanovic JP, Mittal P, Kim SK, Gotsch F, Than NG, Mazaki-Tovi S, Vaisbuch E, Erez O, Yeo L, Hassan SS, Sorokin Y (2010) Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations. Ultrasound Obstet Gynecol 35(2):155–162. doi:10.1002/uog.7491
16. Kurmanavicius J, Florio I, Wisser J, Hebisch G, Zimmermann R, Muller R, Huch R, Huch A (1997) Reference resistance indices of the umbilical, fetal middle cerebral and uterine arteries at 24–42 weeks of gestation. Ultrasound Obstet Gynecol 10(2):112–120. doi:10.1046/j.1469-0705.1997.10020112.x
17. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK (1989) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161(5):1200–1204
18. Adekola H, Romero R, Chaemsaithong P, Korzeniewski SJ, Dong Z, Yeo L, Hassan SS, Chaiworapongsa T (2014) Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J Matern Fetal Neonatal Med. doi:10.3109/14767058.2014.964676
19. Delehedde M, Devenyns L, Maurage CA, Vives RR (2013) Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. I J Cell Biol 2013:705027. doi:10.1155/2013/705027
20. Shin JW, Huggenberger R, Detmar M (2008) Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis. Blood 112(6):2318–2326. doi:10.1182/blood-2008-05-156331
21. Ahn H, Park J, Gilman-Sachs A, Kwak-Kim J (2011) Immunologic characteristics of preeclampsia, a comprehensive review. Am J Reprod Immunol 65(4):377–394. doi:10.1111/j.1600-0897.2010.00913.x
22. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y (2007) The role of the immune system in preeclampsia. Mol Asp Med 28(2):192–209. doi:10.1016/j.mam.2007.02.006
23. Redman CW, Sacks GP, Sargent IL (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180(2 Pt 1):499–506
24. Pober JS, Cotran RS (1990) Cytokines and endothelial cell biology. Physiol Rev 70(2):427–451
25. Savaj S, Vaziri N (2012) An overview of recent advances in pathogenesis and diagnosis of preeclampsia. Iran J Kidney Dis 6(5):334–338
26. Rennel E, Mellberg S, Dimberg A, Petersson L, Botling J, Ameur A, Westholm JO, Komorowski J, Lassalle P, Cross MJ, Gerwins P (2007) Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer. Exp Cell Res 313(7):1285–1294. doi:10.1016/j.yexcr.2007.01.021